Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer
Clinical trial NCT07014410 · RECRUITING
Trial details
- NCT number
- NCT07014410
- Sponsor
- Zhejiang Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-01
- Primary completion
- 2027-12-31
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.